The ADA recommended doctors avoid prescribing unapproved, off-brand versions of drugs like Wegovy, wading into a dispute that has gripped the FDA and compounding pharmacies over the past few months.

Dr. Scott Gottlieb joins 'Fast Money' to talk how a Trump administration could impact the GLP-1 drug industry.

We recently compiled a list of the 10 High Growth Healthcare Stocks to Invest in Now. In this article, we are going to take a ...

Using the Saxenda pen correctly is essential for safe and effective weight loss management. While the pen is designed to be user-friendly, many people make mistakes that can reduce its effectiveness ...

The price of Wegovy, the diabetes control drug's glamorous anti-obesity sibling, may also be falling, according to a Health ...

Ozempic and other weight loss drugs make you lose muscle, too. Here's why that's not as bad as it sounds, but you should still work on building muscle, too.

Clinicians and patients should avoid using compounded GLP-1 products that are not FDA-approved, the American Diabetes Association wrote in a guidance statement published Dec. 2 in Diabetes Care. The ...

GLP-1 receptor agonist use is associated with benefits in a number of different disease and may help treat patients with lupus nephritis.

Another study suggests that weight-loss meds like Wegovy (NVO) and Mounjaro (LLY) can help people cut back on drinking ...

More than 7 million Americans struggling with obesity would become eligible for coverage under the proposed change ...

Unless you have been living under a rock, you’ll know that anti-obesity GLP-1 drugs are the next big thing in pharma, with ...

Skeletal Muscle Health Amid Growing Use of Weight Loss Medication. A recent commentary published in The Lancet journal highlights the critical importance of skeletal ...